When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. (Q38887426)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. |
scientific article |
Statements
When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study (English)
Linda-Gail Bekker
2 references
Robin Wood
2 references
Motasim Badri
Susan Cleary
Gary Maartens
Jennifer Pitt
Catherine Orrell